Endocrinology Research

Our research efforts are focused on three major areas:

• Type I Diabetes

  Clinical trials include the NIH sponsored Diabetes Prevention Trial Type I, and as part of this national consortium of pediatric endocrinologists and scientists, we are studying prevention of Type I Diabetes in relatives and preserving the function of the insulin producing pancreatic islet cells in children with new onset diabetes. We are also testing new analogs of insulin for use in pediatric populations and beta testing new insulin pump delivery systems and technologies.

• Type II Diabetes

  With the current epidemic of Type II diabetes in children and in childhood obesity, we are conducting trials to measure safety and efficacy of FDA approved oral medications for children.

• Growth Hormone administration

  Our practice participates in the National Growth Hormone Registry that follows some 45,000 children treated with growth hormone for safety and efficacy. In addition, we are involved in growth hormone studies for alternate methods of dosing based on IGF-1 levels rather than the traditional dose based on weight.

For more information about current and future studies, contact our Research Coordinator, Heather Speer, MPH, CCRC at (714) 532-8613.